These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 1334821)
41. Carotid Atherosclerosis Evolution When Targeting a Low-Density Lipoprotein Cholesterol Concentration <70 mg/dL After an Ischemic Stroke of Atherosclerotic Origin. Amarenco P; Hobeanu C; Labreuche J; Charles H; Giroud M; Meseguer E; Lavallée PC; Gabriel Steg P; Vicaut É; Bruckert E; Touboul PJ Circulation; 2020 Aug; 142(8):748-757. PubMed ID: 32594766 [TBL] [Abstract][Full Text] [Related]
42. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Noto N; Okada T; Yamasuge M; Taniguchi K; Karasawa K; Ayusawa M; Sumitomo N; Harada K Pediatrics; 2001 May; 107(5):1095-9. PubMed ID: 11331692 [TBL] [Abstract][Full Text] [Related]
43. [Ultrasonographic assessment of carotid atherosclerosis emphasizing the variety of intimal-medial thickness and the relationship with coronary risk factors]. Sugo A; Nakajima S; Kurata T; Mokuno H; Daida H; Yamaguchi H J Cardiol; 1997 Dec; 30(6):321-9. PubMed ID: 9436074 [TBL] [Abstract][Full Text] [Related]
44. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Lonn E; Yusuf S; Dzavik V; Doris C; Yi Q; Smith S; Moore-Cox A; Bosch J; Riley W; Teo K; Circulation; 2001 Feb; 103(7):919-25. PubMed ID: 11181464 [TBL] [Abstract][Full Text] [Related]
45. Apo-lipoprotein profile in subjects with extracranial carotid atherosclerosis. Barbagallo CM; Averna MR; Novo S; Cavera G; Noto D; Liquori M; Spano L; Notarbartolo A Int Angiol; 1994 Sep; 13(3):223-8. PubMed ID: 7822898 [TBL] [Abstract][Full Text] [Related]
46. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Hulthe J; Wikstrand J; Emanuelsson H; Wiklund O; de Feyter PJ; Wendelhag I Stroke; 1997 Jun; 28(6):1189-94. PubMed ID: 9183349 [TBL] [Abstract][Full Text] [Related]
47. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial. Zanchetti A; Crepaldi G; Bond MG; Gallus G; Veglia F; Mancia G; Ventura A; Baggio G; Sampieri L; Rubba P; Sperti G; Magni A; Stroke; 2004 Dec; 35(12):2807-12. PubMed ID: 15514192 [TBL] [Abstract][Full Text] [Related]
48. Effect of intensive statin therapy on regression of carotid intima-media thickness in patients with subclinical carotid atherosclerosis (a prospective, randomized trial: PEACE (Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-lowering Therapy) study). Ikeda K; Takahashi T; Yamada H; Matsui K; Sawada T; Nakamura T; Matsubara H; Eur J Prev Cardiol; 2013 Dec; 20(6):1069-79. PubMed ID: 22689416 [TBL] [Abstract][Full Text] [Related]
49. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Espeland MA; Applegate W; Furberg CD; Lefkowitz D; Rice L; Hunninghake D Am J Epidemiol; 1995 Nov; 142(10):1011-9. PubMed ID: 7485045 [TBL] [Abstract][Full Text] [Related]
50. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Blankenhorn DH; Selzer RH; Crawford DW; Barth JD; Liu CR; Liu CH; Mack WJ; Alaupovic P Circulation; 1993 Jul; 88(1):20-8. PubMed ID: 8319334 [TBL] [Abstract][Full Text] [Related]
51. Elevation of HDL-C in response to statin treatment is involved in the regression of carotid atherosclerosis. Ishigaki Y; Kono S; Katagiri H; Oka Y; Oikawa S; J Atheroscler Thromb; 2014; 21(10):1055-65. PubMed ID: 24930383 [TBL] [Abstract][Full Text] [Related]
52. Measurement of plasma ox-LDL and carotid IMT may represent useful markers for atherosclerosis and may represent potential targets for therapeutic interventions. Savoiu G; Drăgan S; Cristescu C; Serban C; Noveanus L; Ionescu D; Nicola T; Duicu O; Raducan A; Voicu M Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):397-401. PubMed ID: 21491821 [TBL] [Abstract][Full Text] [Related]
53. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial. Shukla A; Sharma MK; Jain A; Goel PK Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637 [TBL] [Abstract][Full Text] [Related]
54. Modifying the natural history of atherosclerosis: the SECURE trial. Lonn E Int J Clin Pract Suppl; 2001 Jan; (117):13-8. PubMed ID: 11715353 [TBL] [Abstract][Full Text] [Related]
55. Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound. The ARIC Investigators. Atherosclerosis Risk in Communities Study. Råstam L; Lindberg G; Folsom AR; Burke GL; Nilsson-Ehle P; Lundblad A Int J Epidemiol; 1996 Oct; 25(5):953-8. PubMed ID: 8921480 [TBL] [Abstract][Full Text] [Related]
56. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Salonen R; Seppänen K; Rauramaa R; Salonen JT Arteriosclerosis; 1988; 8(6):788-92. PubMed ID: 3196222 [TBL] [Abstract][Full Text] [Related]
57. Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal--medial thickness: a meta-analysis of randomized controlled trials. Bedi US; Singh M; Singh PP; Bhuriya R; Bahekar A; Molnar J; Khosla S; Arora R J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):268-73. PubMed ID: 20472815 [TBL] [Abstract][Full Text] [Related]
58. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Ryu JE; Howard G; Craven TE; Bond MG; Hagaman AP; Crouse JR Stroke; 1992 Jun; 23(6):823-8. PubMed ID: 1595099 [TBL] [Abstract][Full Text] [Related]
59. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Jukema JW; Bruschke AV; van Boven AJ; Reiber JH; Bal ET; Zwinderman AH; Jansen H; Boerma GJ; van Rappard FM; Lie KI Circulation; 1995 May; 91(10):2528-40. PubMed ID: 7743614 [TBL] [Abstract][Full Text] [Related]